Literature DB >> 35044648

A Method of Bone-Metastatic Tumor Progression Assessment in Mice Using Longitudinal Radiography.

Matthew R Eber1, Juan Miguel Jiménez-Andrade2, Christopher M Peters3, Yusuke Shiozawa4.   

Abstract

Many types of solid tumors metastasize to the bone, where it causes significant morbidity and mortality in patients with advanced disease. Bone metastases are not only incurable but also affect bone health which impairs patients' quality of life. In order to understand the mechanisms and develop effective treatments for bone-metastatic disease, it is first necessary to develop animal models that permit the assessment of tumor growth in the bone and progressive structural changes of the bone simultaneously. Longitudinal analysis of bone tumor progression is generally performed by bioluminescent imaging; however, this method is not able to assess progressive structural changes of the bone. Here, we describe a simple method for assessment of bone lesions using a scoring system that takes into account disease burden and bone destruction using longitudinal radiographs.
© 2022. Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  Bone metastasis; Intrafemoral injection; Radiography

Mesh:

Year:  2022        PMID: 35044648      PMCID: PMC9082521          DOI: 10.1007/978-1-0716-1896-7_1

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  11 in total

Review 1.  Metastasis to bone: causes, consequences and therapeutic opportunities.

Authors:  Gregory R Mundy
Journal:  Nat Rev Cancer       Date:  2002-08       Impact factor: 60.716

Review 2.  Experimental design for stable genetic manipulation in mammalian cell lines: lentivirus and alternatives.

Authors:  Robert F Shearer; Darren N Saunders
Journal:  Genes Cells       Date:  2014-10-13       Impact factor: 1.891

3.  Osteoprotegerin blocks bone cancer-induced skeletal destruction, skeletal pain and pain-related neurochemical reorganization of the spinal cord.

Authors:  P Honore; N M Luger; M A Sabino; M J Schwei; S D Rogers; D B Mach; P F O'keefe; M L Ramnaraine; D R Clohisy; P W Mantyh
Journal:  Nat Med       Date:  2000-05       Impact factor: 53.440

Review 4.  Skeletal complications in cancer patients with bone metastases.

Authors:  Shunsuke Tsuzuki; Sun Hee Park; Matthew R Eber; Christopher M Peters; Yusuke Shiozawa
Journal:  Int J Urol       Date:  2016-08-03       Impact factor: 3.369

5.  Bone health in cancer patients: ESMO Clinical Practice Guidelines.

Authors:  R Coleman; J J Body; M Aapro; P Hadji; J Herrstedt
Journal:  Ann Oncol       Date:  2014-04-29       Impact factor: 32.976

6.  Models of Prostate Cancer Bone Metastasis.

Authors:  Sun Hee Park; Matthew Robert Eber; Yusuke Shiozawa
Journal:  Methods Mol Biol       Date:  2019

Review 7.  Bioluminescent imaging: a critical tool in pre-clinical oncology research.

Authors:  Karen O'Neill; Scott K Lyons; William M Gallagher; Kathleen M Curran; Annette T Byrne
Journal:  J Pathol       Date:  2010-02       Impact factor: 7.996

8.  Histomorphometric analysis of sclerotic bone metastases from prostatic carcinoma special reference to osteomalacia.

Authors:  S A Charhon; M C Chapuy; E E Delvin; A Valentin-Opran; C M Edouard; P J Meunier
Journal:  Cancer       Date:  1983-03-01       Impact factor: 6.860

9.  Targeting cells of the myeloid lineage attenuates pain and disease progression in a prostate model of bone cancer.

Authors:  Michelle L Thompson; Juan M Jimenez-Andrade; Stephane Chartier; James Tsai; Elizabeth A Burton; Gaston Habets; Paul S Lin; Brian L West; Patrick W Mantyh
Journal:  Pain       Date:  2015-09       Impact factor: 7.926

10.  Targeting the S1P/S1PR1 axis mitigates cancer-induced bone pain and neuroinflammation.

Authors:  Shaness A Grenald; Timothy M Doyle; Hong Zhang; Lauren M Slosky; Zhoumou Chen; Tally M Largent-Milnes; Sarah Spiegel; Todd W Vanderah; Daniela Salvemini
Journal:  Pain       Date:  2017-09       Impact factor: 7.926

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.